S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
Senate works through night, virus aid on path to passage
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
Senate works through night, virus aid on path to passage
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
Senate works through night, virus aid on path to passage
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
Senate works through night, virus aid on path to passage
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
Log in
NASDAQ:RCKT

Rocket Pharmaceuticals Earnings Date, Estimates & History

Top-Rated Stocks  
$52.42
+2.36 (+4.71 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$46.94
Now: $52.42▼
$52.53
50-Day Range
$50.06
MA: $56.71▼
$65.91
52-Week Range
$9.01
Now: $52.42▼
$67.48
Volume458,005 shs
Average Volume473,056 shs
Market Capitalization$2.90 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.05

Earnings

Rocket Pharmaceuticals (NASDAQ:RCKT) Earnings Information

Rocket Pharmaceuticals last posted its quarterly earnings results on February 25th, 2021. The biotechnology company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.52) by $0.56. Rocket Pharmaceuticals has generated ($1.58) earnings per share over the last year. Rocket Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Rocket Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Rocket Pharmaceuticals (NASDAQ:RCKT) Earnings Estimates

2021 EPS Consensus Estimate: ($2.51)
2022 EPS Consensus Estimate: ($3.87)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20214($0.70)($0.50)($0.59)
Q2 20214($0.75)($0.51)($0.62)
Q3 20214($0.80)($0.53)($0.66)
Q4 20213($0.70)($0.55)($0.64)
Q1 20222($1.11)($0.75)($0.93)
Q2 20222($1.07)($0.75)($0.91)
Q3 20222($1.09)($0.80)($0.95)
Q4 20222($1.11)($1.05)($1.08)

Rocket Pharmaceuticals (NASDAQ RCKT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/5/2021
(Estimated)		       
2/25/202112/31/2020($0.52)($1.08)($1.08)N/A
11/4/20209/30/2020($0.45)($0.53)($0.53)N/A
8/5/20206/30/2020($0.50)($0.45)($0.45)N/A
5/6/20203/31/2020($0.48)($0.45)($0.45)N/A
3/5/202012/31/2019($0.49)($0.39)($0.39)N/A
11/7/2019Q3($0.4920)($0.38)($0.38)N/A
8/7/2019Q2 2019($0.4820)($0.38)($0.38)N/A
5/8/20193/31/2019($0.63)($0.43)($0.43)N/A
3/7/201912/31/2018($0.45)($0.66)($0.66)N/A
11/7/20189/30/2018($0.43)($0.40)($0.40)N/A
8/8/2018Q2 2018($0.3650)($0.40)($0.40)N/A
5/11/2018Q1 2018($0.28)($0.42)($0.42)N/A
8/3/2017Q2 2017($0.47)($0.24)($0.24)N/A
5/10/2017Q1 2017($0.3930)($0.40)($0.40)N/A
3/16/2017Q4 2016($0.4320)($0.4810)($0.48)N/A
11/9/2016Q3 2016($0.45)($0.41)($0.41)N/A
8/10/2016Q2($0.40)($0.33)($0.33)N/A
5/11/2016Q1($0.22)($0.38)($0.38)N/A
3/23/2016Q4($0.37)($0.13)N/A
11/12/2015Q3 2015($1.84)($1.00)$7.92N/A
8/6/2015Q2 2015($0.29)($0.26)($0.37)N/A
5/15/2015Q1 2015$0.80$2.44N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/7/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.